Retinal imaging is a technique that is used to analyze and diagnose the condition of a patient’s retina. Retinal imaging devices (RID) use high-resolution imaging systems to capture inside area pictures of an eye. The captured image helps Virtual Private Network (VSP) network doctors assess the health of the retina, which helps in the detection and management of eye and health conditions such as diabetes, glaucoma, and macular degeneration.
Carl Zeiss Meditec AG and Topcon Corporation — Notable Market Players in Retinal Imaging Devices Market
The growth of the Retinal Imaging Devices market is attributed to the rising prevalence of eye diseases, growing global initiatives for blindness, and technological advancements. However, the high cost of OCT devices hampers the market growth.
Market leaders operating in the market have undertaken various organic and inorganic growth strategies. The retinal imaging devices market majorly consists of players such as Carl Zeiss Meditec, Revenio Group Oyj, Nikon Corporation, Optomed, Topcon Corporation, Imagine Eyes, Epipole Ltd, Forus Health Pvt Ltd, Eyenuk Inc, and Phoenix Technology Group LLC.
Several in organic approaches, such as product launches, and expansion in the endocrine disruptor screening, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
A few growth strategies adopted by the players operating in the retinal imaging devices market are listed below:
| Month & Year | Description |
| Jan-2022 | Oulu University Hospital’s ophthalmology department has conducted a pilot screening study with the purpose to compare the performance and image quality of the Optomed Aurora handheld fundus camera to the standard desktop fundus cameras normally used in diabetic retinopathy (DR) screening. |
| Sep-2021 | A fully connected and integrated approach keeps ZEISS at the forefront of ophthalmology with new data management innovations across devices, workflow solutions and software applications. |
| Aug-2020 | ZEISS IOLMaster software update enables greater cataract workflow efficiency to support better outcomes for surgeons and patients. |
| Dec-2019 | The Food and Drug Administration in the USA and CE certified in Europe approved the DRSplus imaging device. DRSplus is a confocal fundus imaging system that utilizes a white LED illumination principle to produce a TrueColor and detail-rich images of the fundus. DRSplus is a fast and fully automated device. |
| Sep-2021 | The Japan International Eye Hospital (Hanoi, Vietnam) introduces the first device of ultra-widefield(UWF) imaging device in Vietnam in 2021. Optos ultra-widefield retinal imaging device of Nikon is the retinal imagining device established in the hospital |
| Jul-2021 | Topcon Corporation has acquired VISIA Imaging S.r.l. This acquisition enhances Topcon’s development and manufacturing capabilities of anterior segment devices and software, which complements the company’s strong portfolio of fundus imaging devices that includes fundus cameras and optical coherence tomography (OCT). The acquisition further reinforces Topcon’s position as a leading ophthalmic diagnostic device manufacturer. |
| Mar-2021 | Revenio Group Plc acquired the Australian CERA Technologies Pty Ltd (“Oculo”), a company specialized in developing software designed to share clinical imaging, referrals, and other clinical correspondence securely and instantly between health care professionals. Corporate Acquisition is an integral part of Revenio’s strategy, and the Company takes with it a significant step towards software-connected eye care. Also, the Corporate Acquisition supports Revenio’s position as a key player in the field of comprehensive clinical eye diagnostics solutions and opens up new opportunities in the rapidly growing areas of eye-related telehealth and technology-enhanced eye care models. |
